Default company panoramic image
Logo

Ligandal Technology

Gene editing nanoparticles that work in people and are > 80% efficient. Tested on Osteoporosis cells and helped create 5x more bone stuff.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Oakland, CA, USA
  • Currency USD

Company Summary

Ligandal has invented a new method of altering genes in living cells.. We can efficiently deliver therapeutic tools (genes, proteins, drugs) anywhere in a living animal without the side effects and more effectively than current medicines. The applications of this tech are vast. They include gene therapy, drug delivery without side effects, and tissue rejuvenation. These are all new multi-billion dollar domestic markets that we are creating.

Team

  • Default avatar
    Andre Watson
    Chief Science Officer

  • Default avatar
    Alexander Honkala
    Chief Technical Officer

  • Default avatar
    Edwin Urey
    Strategic Director

    BA Amherst College. Candidate for JD St. John's University. Strategic Director Edgail Inc.

  • Default avatar
    Patrick Nelson
    Director of Corporate Development

Advisors

  • Default avatar
    Jonathan kaplan
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Deogratias Delaney
    Unconfirmed